CL2009001025A1 - Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco. - Google Patents

Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.

Info

Publication number
CL2009001025A1
CL2009001025A1 CL2009001025A CL2009001025A CL2009001025A1 CL 2009001025 A1 CL2009001025 A1 CL 2009001025A1 CL 2009001025 A CL2009001025 A CL 2009001025A CL 2009001025 A CL2009001025 A CL 2009001025A CL 2009001025 A1 CL2009001025 A1 CL 2009001025A1
Authority
CL
Chile
Prior art keywords
buffering agent
alkaline buffering
filler
useful
active ingredient
Prior art date
Application number
CL2009001025A
Other languages
English (en)
Inventor
Li-Ian Chen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41255405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009001025(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CL2009001025A1 publication Critical patent/CL2009001025A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacture Of Tobacco Products (AREA)

Abstract

Composición de pastilla oral para chupar que comprende a) un componente de gránulo patrón comprendiendo al menos un agente tampón alcalino, al menos un modificador de la disolución y al menos una carga; b) un principio activo de nicotina y al menos un agente tampón alcalino; útil para eliminar o reducir el uso del tabaco.
CL2009001025A 2008-05-01 2009-04-29 Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco. CL2009001025A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4951508P 2008-05-01 2008-05-01

Publications (1)

Publication Number Publication Date
CL2009001025A1 true CL2009001025A1 (es) 2010-09-24

Family

ID=41255405

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001025A CL2009001025A1 (es) 2008-05-01 2009-04-29 Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.

Country Status (18)

Country Link
US (3) US8501164B2 (es)
EP (1) EP2285411B1 (es)
JP (2) JP5893405B2 (es)
CN (1) CN102076362B (es)
AR (1) AR071420A1 (es)
AU (1) AU2009243065B2 (es)
BR (1) BRPI0911847B8 (es)
CA (1) CA2723011A1 (es)
CL (1) CL2009001025A1 (es)
DK (1) DK2285411T3 (es)
ES (1) ES2605244T3 (es)
HU (1) HUE031175T2 (es)
MX (1) MX2010011929A (es)
MY (1) MY164646A (es)
PL (1) PL2285411T3 (es)
PT (1) PT2285411T (es)
RU (1) RU2458692C2 (es)
WO (1) WO2009134947A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2536409A4 (en) 2010-02-18 2013-07-17 Jatin Vasant Thakkar NICOTINE-CONTAINING SOFT GELATINETABLETTEN
UA112974C2 (uk) 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
AR096223A1 (es) * 2013-05-10 2015-12-16 Glaxosmithkline Llc Pastilla de nicotina para administración oral
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
EP3052081B1 (en) 2013-10-03 2020-12-09 Altria Client Services LLC Lozenge
US12274276B2 (en) 2013-10-03 2025-04-15 Altria Client Services Llc Dissolvable-chewable tablet
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
ES2814296T3 (es) 2016-04-21 2021-03-26 Fertin Pharma As Producto para administración de nicotina, usos relacionados y formas de dosificación oral y métodos de producción
WO2019110072A1 (en) 2017-12-08 2019-06-13 Fertin Pharma A/S Nicotine tablet
EP3720497A1 (en) * 2017-12-08 2020-10-14 Fertin Pharma A/S High nicotine concentration
ES3015556T3 (en) * 2017-12-08 2025-05-06 Fertin Pharma As Solid oral nicotine formulation
CA3085066C (en) * 2017-12-08 2024-01-09 Fertin Pharma A/S Formulations providing high nicotine concentrations
CA3040547C (en) 2019-04-17 2021-12-07 Medcan Pharma A/S Cannabinoid lozenge formulation
US11759419B2 (en) * 2019-10-11 2023-09-19 Fertin Pharma A/S Compressed nicotine lozenge
US12702643B2 (en) 2019-10-11 2026-08-11 Fertin Pharma A/S Ion-exchange composition with water-soluble mucoadhesive polymers
US11000540B1 (en) * 2019-11-22 2021-05-11 Al Siamon Treatment for reducing adverse events including chemotherapy discomfort and other conditions
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
CN115003281A (zh) * 2020-01-15 2022-09-02 麦克内尔股份公司 锭剂
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US20220387328A1 (en) * 2021-06-04 2022-12-08 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Dosage form for nicotine replacement therapy
EP4408184A1 (en) * 2021-09-30 2024-08-07 Nicoventures Trading Limited Oral gum composition
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
CN115813007B (zh) * 2022-12-22 2025-02-14 东莞市吉纯生物技术有限公司 尼古丁口含制品及制备方法和碱性电解水的制备方法
DK182273B1 (en) * 2023-07-07 2026-01-30 Fertin Pharma As Dissolvable orally adhering nicotine tablet
DK182278B1 (en) * 2023-07-07 2026-02-04 Fertin Pharma As Dissolvable orally adhering tablet

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
TR199802305T2 (xx) 1996-05-13 2002-06-21 Norvartis Consumer Health S.A. Yanaktan uygulama y�ntemi.
ATE447398T1 (de) 1998-12-18 2009-11-15 Alza Corp Durchsichtige transdermale nicotinabgabevorrichtungen
FR2792200B3 (fr) * 1999-04-16 2001-06-08 Unicliffe Ltd Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer
WO2002085119A1 (en) 2001-04-20 2002-10-31 Lavipharm Laboratories Inc. Intraoral delivery of nicotine for smoking cessation
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
MXPA04006163A (es) 2001-12-20 2004-11-01 Pharmacia Corp Formas de dosis de liberacion sostenida del orden-cero y metodo de fabricacion de las mismas.
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
EP1578422B1 (en) * 2002-12-20 2007-04-11 NicoNovum AB A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
US20040182403A1 (en) 2003-02-28 2004-09-23 Sven-Borje Andersson Container comprising nicotine and the use and manufacture thereof
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
DK1663168T3 (da) 2003-09-08 2009-06-08 Mcneil Ab Nikotinformuleringer og anvendelse deraf
US20050123502A1 (en) * 2003-10-07 2005-06-09 Chan Shing Y. Nicotine containing oral compositions
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
AU2007224586A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Stable lozenge compositions providing rapid release of nicotine
US20070269386A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20070269492A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20080287507A1 (en) 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
US20080286340A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US20090004248A1 (en) 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US20090164008A1 (en) * 2007-12-21 2009-06-25 Xin Hong Lens surface with combined diffractive, toric, and aspheric components
PT2361081T (pt) 2008-10-14 2016-09-05 Mcneil Ab Forma de dosagem intra-oral multiporção e seu uso
EP2233134A1 (en) 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
US8784781B2 (en) 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency

Also Published As

Publication number Publication date
BRPI0911847A2 (pt) 2015-10-06
AU2009243065B2 (en) 2013-05-23
EP2285411B1 (en) 2016-09-21
CN102076362B (zh) 2015-01-21
JP6159761B2 (ja) 2017-07-05
US8940772B2 (en) 2015-01-27
BRPI0911847B8 (pt) 2021-05-25
EP2285411A4 (en) 2011-05-18
US20110110880A1 (en) 2011-05-12
RU2458692C2 (ru) 2012-08-20
PL2285411T3 (pl) 2017-07-31
WO2009134947A1 (en) 2009-11-05
US8501164B2 (en) 2013-08-06
CN102076362A (zh) 2011-05-25
RU2010149050A (ru) 2012-06-10
HUE031175T2 (en) 2017-06-28
DK2285411T3 (da) 2017-01-02
JP2015232012A (ja) 2015-12-24
HK1153146A1 (zh) 2012-03-23
AR071420A1 (es) 2010-06-16
US20130289079A1 (en) 2013-10-31
EP2285411A1 (en) 2011-02-23
PT2285411T (pt) 2016-11-25
US20150105431A1 (en) 2015-04-16
AU2009243065A1 (en) 2009-11-05
BRPI0911847A8 (pt) 2018-03-06
BRPI0911847B1 (pt) 2021-04-13
JP5893405B2 (ja) 2016-03-23
MX2010011929A (es) 2010-11-30
MY164646A (en) 2018-01-30
CA2723011A1 (en) 2009-11-05
ES2605244T3 (es) 2017-03-13
JP2011519862A (ja) 2011-07-14

Similar Documents

Publication Publication Date Title
ECSP088239A (es) Composición de liberación de fármaco sostenida
ECSP088240A (es) Composición de trazodona para administración una vez por día
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
AR071420A1 (es) Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla
CL2013001586A1 (es) Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion.
AR069875A1 (es) Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion
CR9864A (es) Formas de presentacion farmaceutica solidas de administracion oral con liberacion rapida de principio activo
BR112014019262A8 (pt) Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas
CL2009001600A1 (es) Composicion que comprende una fuente de dioxido de cloro, al menos 5 ppm de dioxido de cloro y no mas de 0,25 mg de aniones oxicloro por gramo de composiicon; util para aliviar infecciones de tejido en la cavidad oral.
CL2010001620A1 (es) Composicion agricola, del cuidado personal, del cuidado de la casa y de revestimiento que comprende silicona y otro componente adicional; emulsion acuosa y no acuosa que comprende la composicion agricola; y metodo para formular dichas composiciones (div. sol. n° 656-207).
AR076153A1 (es) Forma de dosificacion intra-oral de multiples porciones con propiedades organolepticas. formulaciones
CL2010001366A1 (es) Composicion farmaceutica de liberacion controlada que comprende topiramato, celulosa microcristalina y metilcelulosa; preparado farmaceutico que la comprende, util para tratar la obesidad, diabetes o una afeccion relacionada.
CO6311067A2 (es) Preparación de comprimido con liberación retardada que contiene polivinilpirrolidonas y principio activo
DOP2013000224A (es) Uso de 2,3-dihidroimidazo[1,2-c] quinazolinas sustituidas.
MX2014008284A (es) Formulacion de liberacion retardada para reducir la frecuencia de orinar y metodos de uso de esta.
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
MX2014008283A (es) Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
UY31780A (es) Fenoxibenzamidas sustituidas
CL2007003587A1 (es) Compuestos derivados de pirimidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para tratar o prevenir la infeccion de la hepatitis c.
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
CR9259A (es) Composicion antihelmintica
AR060869A1 (es) Composicion farmaceutica solida de gabapentina
EA201070806A1 (ru) Состав медленного высвобождения на основе ассоциации гликогена и альгината
CO6321223A2 (es) Formulacion farmaceutica solida que contiene ciclostazol
CL2011000805A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion de lictus en pacientes que padecen fibrilacion auricular.